İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2015

Management and outcome of topical beta-blocker induced atrioventricular block

Cardiovascular Journal Of Africa

YÖKSİS OpenAlex Açık erişim · green SJR Q3 JCR Q4 Atıf 13 Yüzdelik 71.6% FWCI 0.54
Yıl
2015
ISSN
1995-1892
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

BACKGROUND: Topical beta-blockers have a well-established role in the treatment of glaucoma. We aimed to investigate the outcome of patients who developed symptomatic atrioventricular (AV) block induced by topical beta-blockers. METHODS: All patients admitted or discharged from our institution, the Siyami Ersek Training and Research Hospital, between January 2009 and January 2013 with a diagnosis of AV block were included in the study. Subjects using ophthalmic beta-blockers were recruited and followed for permanent pacemaker requirement during hospitalisation and for three months after discontinuation of the drug. A permanent pacemaker was implanted in patients in whom AV block persisted beyond 72 hours or recurred during the follow-up period. RESULTS: A total of 1 122 patients were hospitalised with a diagnosis of AV block and a permanent pacemaker was implanted in 946 cases (84.3%) during the study period. Thirteen patients using ophthalmic beta-blockers for the treatment of glaucoma and no other rate-limiting drugs were included in the study. On electrocardiography, eight patients had complete AV block and five had high-degree AV block. The ophthalmic beta-blockers used were timolol in seven patients (55%), betaxolol in four (30%), and cartelol in two cases (15%). The mean duration of ophthalmic beta-blocker treatment was 30.1 ± 15.9 months. After drug discontinuation, in 10 patients the block persisted and a permanent pacemaker was implanted. During follow up, one more patient required pacemaker implantation. Therefore in total, pacemakers were implanted in 11 out of 13 patients (84.6%). The pacemaker implantation rate did not differ according to the type of topical beta-blocker used (p = 0.37). The presence of infra-nodal block on electrocardiography was associated with higher rates of pacemaker implantation. CONCLUSION: Our results indicate that topical beta-blockers for the treatment of glaucoma may cause severe conduction abnormalities and when AV block occurs, pacemaker implantation is required in a high percentage of the patients.

Konular

  • Glaucoma and retinal disorders
  • Intraocular Surgery and Lenses
  • Drug-Induced Ocular Toxicity

Birincil konu Glaucoma and retinal disorders

Yazarlar

  1. KAZIM SERHAN ÖZCAN
  2. BARIŞ GÜNGÖR
  3. DAMİRBEK OSMONOV
  4. AHMET İLKER TEKKEŞİN
  5. SERVET ALTAY
  6. AHMET EKMEKÇİ
  7. ERCAN TOPRAK
  8. ERSİN YILDIRIM
  9. ALİ NAZMİ ÇALIK ÜSKÜDAR ÜNİVERSİTESİ
  10. AHMET TAHA ALPER
  11. KADİR GÜRKAN
  12. İZZET ERDİNLER